Vinorelbine Injection

Generic name: Pronounced as (vi nor' el been)
Brand names
  • Navelbine®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 04/15/2020

Vinorelbine should be given only under the supervision of a doctor with experience in the use of chemotherapy medications.

Vinorelbine can cause a severe decrease in the number of blood cells in your bone marrow. This may cause certain symptoms and may increase the risk that you will develop a serious infection. Your doctor will order laboratory tests before and during your treatment to check the number of white blood cells in your blood. Your doctor may decrease your dose, or delay,, interrupt, or stop your treatment if the number of white blood cells is too low. If you experience any of the following symptoms, call your doctor immediately: fever, sore throat, ongoing cough and congestion, or other signs of infection.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to vinorelbine.

Vinorelbine is used alone and in combination with other medications to treat non-small cell lung cancer (NSCLC) that has spread to nearby tissues or to other parts of the body. Vinorelbine is in a class of medications called vinca alkaloids. It works by slowing or stopping the growth of cancer cells in your body.

Vinorelbine comes as a solution (liquid) to be injected intravenously (into a vein) by a doctor or nurse in a medical facility. It is usually given once a week. The length of treatment depends on how well your body responds to treatment with vinorelbine.

You should know that vinorelbine should be administered only into a vein. However, it may leak into surrounding tissue causing severe irritation or damage. Your doctor or nurse will monitor the area near where the medication was injected. If you experience any of the following symptoms, tell your doctor immediately: pain, itching, redness, swelling, blisters, or sores near the place where the medication was injected.

Vinorelbine is also sometimes used to treat breast cancer, cancer of the esophagus (tube that connects the mouth and stomach), and soft tissue sarcomas (cancer that forms in muscles). Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving vinorelbine,

  • tell your doctor and pharmacist if you are allergic to vinorelbine, any other medications, or any of the ingredients in vinorelbine injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: certain antifungals such as itraconazole (Onmel, Sporanox, Tolsura) and ketoconazole; clarithromycin ; HIV protease inhibitors including indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra, Technivie, Viekira), and saquinavir (Invirase); or nefazodone. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had liver disease.

  • Tell your doctor if you are pregnant, plan to become pregnant,, or plan to father a child. You or your partner should not become pregnant while you are receiving vinorelbine injection. You must take a pregnancy test before you start treatment to be sure you are not pregnant. If you are a female, use effective birth control during your treatment and for 6 months after your final dose. If you are a male, use effective birth control during your treatment and for 3 months after your final dose. If you or your partner become pregnant while you're receiving vinorelbine injection, call your doctor. Vinorelbine may harm the fetus.

  • tell your doctor if you are breast-feeding. Your doctor will probably tell you not to breastfeed during your treatment and for 9 days after your final dose.

  • you should know that vinorelbine may cause constipation. Talk to your doctor about changing your diet and using other medications to prevent or treat constipation while you are taking vinorelbine.

Your doctor may tell you to be sure to drink enough of water, and eat high fiber foods such as lettuce, spinach, broccoli, squashes, beans, nuts, seeds, fruit, whole wheat bread, whole wheat pasta, or brown rice. Be sure to follow the instructions carefully.

  • Vinorelbine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • diarrhea

    • loss of appetite

    • weight loss

    • change in ability to taste food

    • sores in the mouth and throat

    • hearing loss

    • muscle, or joint pain

    • hair loss

    • lack of energy, not feeling well, tiredness

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment:

    • shortness of breath or difficulty breathing, cough

    • constipation, stomach pain, nausea, vomiting

    • unusual bleeding or bruising

    • hives, itching, rash, difficulty breathing or swallowing

    • swelling of the face, throat, tongue, lips, and eyes

    • blistering or peeling skin

    • yellowing of skin or eyes, dark colored urine, light colored stool

    • numbness, tingling feeling on skin, sensitive skin, decreased sense of touch, or muscle weakness

    • fever, chills, sore throat or other signs of infection

    • chest pain, shortness of breath, coughing up blood

    • red, swollen, tender, or warm arm or leg

  • Talk to your doctor about the risks of receiving vinorelbine injection.

  • Vinorelbine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • sores in the mouth and throat

  • stomach pain

  • constipation

  • fever, sore throat, chills, or other signs of infection

  • loss of the ability to move muscles and to feel a part of the body

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Didehydrodeoxynorvincaleukoblastine

Drug Interaction
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Delavirdine can be decreased when combined with Vinorelbine.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Vinorelbine.
Dolasetron Dolasetron The metabolism of Dolasetron can be decreased when combined with Vinorelbine.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Vinorelbine.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Vinorelbine.
Clopidogrel Clopidogrel The risk or severity of bleeding can be increased when Clopidogrel is combined with Vinorelbine.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Vinorelbine can be decreased when combined with Erythromycin.
Fenofibrate Fenofibrate The metabolism of Vinorelbine can be decreased when combined with Fenofibrate.
Methylergonovine Methylergonovine The metabolism of Vinorelbine can be decreased when combined with Methylergometrine.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mycophenolic acid.
Penbutolol Penbutolol The metabolism of Acebutolol can be decreased when combined with Vinorelbine.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Vinorelbine is combined with Prednisone.
Reserpine Reserpine Reserpine may increase the neurotoxic activities of Vinorelbine.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Vinorelbine.
Triamcinolone Triamcinolone The metabolism of Triamcinolone can be increased when combined with Vinorelbine.
Doxycycline Injection Doxycycline Injection The metabolism of Vinorelbine can be decreased when combined with Doxycycline.
Fluconazole Injection Fluconazole Injection The metabolism of Vinorelbine can be decreased when combined with Fluconazole.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Vinorelbine.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinorelbine.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be increased when combined with Vinorelbine.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Methylprednisolone can be increased when combined with Vinorelbine.
Metoclopramide Injection Metoclopramide Injection The metabolism of Metoclopramide can be decreased when combined with Vinorelbine.
Metronidazole Injection Metronidazole Injection The metabolism of Vinorelbine can be decreased when combined with Metronidazole.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Zidovudine.
Altretamine Altretamine The metabolism of Amphetamine can be decreased when combined with Vinorelbine.
Cyclosporine Cyclosporine Vinorelbine may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Vinorelbine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Vinorelbine.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Vinorelbine.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Hydroxychloroquine.
Orlistat Orlistat The metabolism of Vinorelbine can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Vinorelbine can be increased when combined with Oxcarbazepine.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Temozolomide.
Anakinra Anakinra The metabolism of Vinorelbine can be increased when combined with Anakinra.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Vinorelbine is combined with Linezolid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Vinorelbine.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Vinorelbine.
Etanercept Injection Etanercept Injection The metabolism of Vinorelbine can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Vinorelbine can be increased when combined with Modafinil.
Tenofovir Tenofovir The metabolism of Vinorelbine can be decreased when combined with Tenofovir.
Sirolimus Sirolimus The risk or severity of adverse effects can be increased when Vinorelbine is combined with Sirolimus.
Epinephrine Injection Epinephrine Injection The metabolism of Vinorelbine can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Epirubicin.
Escitalopram Escitalopram The metabolism of Escitalopram can be decreased when combined with Vinorelbine.
Adalimumab Injection Adalimumab Injection The metabolism of Vinorelbine can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Vinorelbine.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Vinorelbine.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Glatiramer.
Atazanavir Atazanavir The metabolism of Vinorelbine can be decreased when combined with Atazanavir.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Vinorelbine.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Vinorelbine.
Mefloquine Mefloquine The metabolism of Vinorelbine can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Vinorelbine can be decreased when combined with Rosuvastatin.
Aprepitant Aprepitant The metabolism of Vinorelbine can be decreased when combined with Aprepitant.
Tegaserod Tegaserod The metabolism of Tegaserod can be decreased when combined with Vinorelbine.
Progesterone Progesterone The metabolism of Progesterone can be increased when combined with Vinorelbine.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of peripheral neuropathy can be increased when Darbepoetin alfa is combined with Vinorelbine.
Infliximab Injection Infliximab Injection The metabolism of Vinorelbine can be increased when combined with Infliximab.
Protriptyline Protriptyline The metabolism of Protriptyline can be decreased when combined with Vinorelbine.
Rifaximin Rifaximin The metabolism of Vinorelbine can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Vinorelbine.
Norethindrone Norethindrone The metabolism of Vinorelbine can be decreased when combined with Norethisterone.
Bosentan Bosentan The metabolism of Vinorelbine can be increased when combined with Bosentan.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Natalizumab.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Vinorelbine.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinorelbine.
Solifenacin Solifenacin The metabolism of Solifenacin can be decreased when combined with Vinorelbine.
Voriconazole Voriconazole The metabolism of Vinorelbine can be decreased when combined with Voriconazole.
Dextroamphetamine Dextroamphetamine The metabolism of Amphetamine can be decreased when combined with Vinorelbine.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Vinorelbine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinorelbine.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Vinorelbine.
Deferasirox Deferasirox The metabolism of Vinorelbine can be increased when combined with Deferasirox.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Vinorelbine.
Felbamate Felbamate The metabolism of Vinorelbine can be increased when combined with Felbamate.
Ranolazine Ranolazine The metabolism of Ranolazine can be decreased when combined with Vinorelbine.
Abatacept Injection Abatacept Injection The metabolism of Abatacept can be increased when combined with Vinorelbine.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Vinorelbine.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Vinorelbine.
Gefitinib Gefitinib Gefitinib may increase the neutropenic activities of Vinorelbine.
Paliperidone Paliperidone The metabolism of Paliperidone can be decreased when combined with Vinorelbine.
Bortezomib Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Vinorelbine.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Vinorelbine.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Vinorelbine.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Vinorelbine.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Vinorelbine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Oxaliplatin.
Posaconazole Posaconazole The metabolism of Vinorelbine can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Vinorelbine can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Vinorelbine.
Bismuth Subsalicylate Bismuth Subsalicylate Vinorelbine may increase the neurotoxic activities of Bismuth subsalicylate.
Darunavir Darunavir The serum concentration of Vinorelbine can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pemetrexed.
Lisdexamfetamine Lisdexamfetamine The metabolism of Lisdexamfetamine can be decreased when combined with Vinorelbine.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Vinorelbine is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Vinorelbine.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Vinorelbine.
Lapatinib Lapatinib The metabolism of Vinorelbine can be decreased when combined with Lapatinib.
Pegfilgrastim Injection Pegfilgrastim Injection The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinorelbine.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Vinorelbine.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Vinorelbine.
Armodafinil Armodafinil The metabolism of Vinorelbine can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Azacitidine.
Ivermectin Ivermectin The metabolism of Vinorelbine can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The risk or severity of adverse effects can be increased when Vinorelbine is combined with Temsirolimus.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Lenalidomide.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Vinorelbine.
Bexarotene Bexarotene The metabolism of Vinorelbine can be increased when combined with Bexarotene.
Budesonide Budesonide The metabolism of Budesonide can be increased when combined with Vinorelbine.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Chloramphenicol can be decreased when combined with Vinorelbine.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Decitabine.
Etravirine Etravirine The metabolism of Vinorelbine can be increased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Mitoxantrone can be decreased when combined with Vinorelbine.
Desvenlafaxine Desvenlafaxine The metabolism of Vinorelbine can be decreased when combined with Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Cevimeline can be decreased when combined with Vinorelbine.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Vinorelbine.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Bendamustine.
Pilocarpine Pilocarpine The metabolism of Vinorelbine can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Vinorelbine.
Certolizumab Injection Certolizumab Injection The metabolism of Certolizumab pegol can be increased when combined with Vinorelbine.
Ixabepilone Injection Ixabepilone Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Irinotecan.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Estramustine.
Mitotane Mitotane The metabolism of Vinorelbine can be increased when combined with Mitotane.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Vinorelbine.
Rufinamide Rufinamide The metabolism of Vinorelbine can be increased when combined with Rufinamide.
Midazolam Midazolam The metabolism of Vinorelbine can be decreased when combined with Midazolam.
Romiplostim Injection Romiplostim Injection The risk or severity of peripheral neuropathy can be increased when Romiplostim is combined with Vinorelbine.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dexrazoxane.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Vinorelbine.
Milnacipran Milnacipran The metabolism of Vinorelbine can be decreased when combined with Milnacipran.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Vinorelbine.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Vinorelbine.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Vinorelbine.
Prasugrel Prasugrel The risk or severity of bleeding can be increased when Prasugrel is combined with Vinorelbine.
Lacosamide Lacosamide The metabolism of Vinorelbine can be decreased when combined with Lacosamide.
Everolimus Everolimus The risk or severity of adverse effects can be increased when Vinorelbine is combined with Everolimus.
Dronedarone Dronedarone The serum concentration of Vinorelbine can be increased when it is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Vinorelbine.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Vinorelbine.
Topotecan Topotecan The metabolism of Topotecan can be increased when combined with Vinorelbine.
Golimumab Injection Golimumab Injection The metabolism of Golimumab can be increased when combined with Vinorelbine.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Vinorelbine.
Asenapine Asenapine Vinorelbine may increase the neurotoxic activities of Asenapine.
Albendazole Albendazole The metabolism of Vinorelbine can be decreased when combined with Albendazole.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Vinorelbine.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Vinorelbine.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Vinorelbine.
Tocilizumab Injection Tocilizumab Injection The metabolism of Tocilizumab can be increased when combined with Vinorelbine.
Fingolimod Fingolimod Vinorelbine may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Cabazitaxel.
Lurasidone Lurasidone Vinorelbine may increase the neurotoxic activities of Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Vinorelbine.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Vinorelbine.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Vinorelbine can be decreased when combined with Aldesleukin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vinorelbine.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Belimumab.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Busulfan.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Vinorelbine.
Linagliptin Linagliptin The metabolism of Vinorelbine can be decreased when combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Vinorelbine can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The metabolism of Vinorelbine can be decreased when combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be increased when combined with Vinorelbine.
Rivaroxaban Rivaroxaban The risk or severity of bleeding can be increased when Rivaroxaban is combined with Vinorelbine.
Ticagrelor Ticagrelor The metabolism of Vinorelbine can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Vinorelbine.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ruxolitinib.
Clobazam Clobazam The metabolism of Vinorelbine can be increased when combined with Clobazam.
Vemurafenib Vemurafenib The metabolism of Vinorelbine can be increased when combined with Vemurafenib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Vinorelbine can be decreased when combined with Ivacaftor.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Vinorelbine.
Crizotinib Crizotinib The metabolism of Vinorelbine can be decreased when combined with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Vinorelbine can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Vinorelbine can be decreased when combined with Naloxone.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Vinorelbine.
Pertuzumab Injection Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Vinorelbine.
Enzalutamide Enzalutamide The metabolism of Vinorelbine can be increased when combined with Enzalutamide.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Vinorelbine.
Regorafenib Regorafenib The metabolism of Vinorelbine can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Vinorelbine.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Corticotropin can be increased when combined with Vinorelbine.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Teriflunomide.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Vinorelbine.
Tofacitinib Tofacitinib Vinorelbine may increase the immunosuppressive activities of Tofacitinib.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Vinorelbine.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Vinorelbine.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Vinorelbine.
Apixaban Apixaban The risk or severity of bleeding can be increased when Apixaban is combined with Vinorelbine.
Dabrafenib Dabrafenib The metabolism of Vinorelbine can be increased when combined with Dabrafenib.
Trametinib Trametinib The metabolism of Vinorelbine can be increased when combined with Trametinib.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Vinorelbine.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Vinorelbine.
Perampanel Perampanel The metabolism of Vinorelbine can be increased when combined with Perampanel.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ibrutinib.
Lomitapide Lomitapide The metabolism of Vinorelbine can be decreased when combined with Lomitapide.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Vinorelbine can be decreased when combined with Simeprevir.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Vinorelbine.
Apremilast Apremilast The metabolism of Apremilast can be increased when combined with Vinorelbine.
Ceritinib Ceritinib The metabolism of Vinorelbine can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Siltuximab can be increased when combined with Vinorelbine.
Eslicarbazepine Eslicarbazepine The metabolism of Vinorelbine can be increased when combined with Eslicarbazepine.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Belinostat.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Idelalisib is combined with Vinorelbine.
Testosterone Injection Testosterone Injection The metabolism of Vinorelbine can be increased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Vinorelbine can be increased when combined with Oritavancin.
Vorapaxar Vorapaxar The metabolism of Vinorelbine can be decreased when combined with Vorapaxar.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Vinorelbine.
Suvorexant Suvorexant The metabolism of Vinorelbine can be decreased when combined with Suvorexant.
Edoxaban Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Vinorelbine.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Vinorelbine.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Blinatumomab.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Vinorelbine.
Tasimelteon Tasimelteon The metabolism of Vinorelbine can be decreased when combined with Tasimelteon.
Lanreotide Injection Lanreotide Injection The metabolism of Vinorelbine can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pirfenidone.
Nintedanib Nintedanib The metabolism of Vinorelbine can be decreased when combined with Nintedanib.
Secukinumab Injection Secukinumab Injection The metabolism of Secukinumab can be increased when combined with Vinorelbine.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be decreased when combined with Vinorelbine.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Vinorelbine.
Lenvatinib Lenvatinib The metabolism of Vinorelbine can be increased when combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of adverse effects can be increased when Vinorelbine is combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Vinorelbine.
Isavuconazonium Injection Isavuconazonium Injection The metabolism of Vinorelbine can be increased when combined with Isavuconazonium.
Prednisolone Prednisolone The metabolism of Prednisolone can be increased when combined with Vinorelbine.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Vinorelbine.
Ziprasidone Injection Ziprasidone Injection The metabolism of Vinorelbine can be decreased when combined with Ziprasidone.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Vinorelbine.
Cobimetinib Cobimetinib The metabolism of Vinorelbine can be decreased when combined with Cobimetinib.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Vinorelbine.
Osimertinib Osimertinib The metabolism of Vinorelbine can be increased when combined with Osimertinib.
Rifapentine Rifapentine The metabolism of Vinorelbine can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Vinorelbine can be increased when combined with Lesinurad.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Vinorelbine can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Dexamethasone can be increased when combined with Vinorelbine.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Vinorelbine.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ixekizumab.
Venetoclax Venetoclax The metabolism of Vinorelbine can be decreased when combined with Venetoclax.
Cobicistat Cobicistat The metabolism of Vinorelbine can be decreased when combined with Cobicistat.
Pimavanserin Pimavanserin Vinorelbine may increase the neurotoxic activities of Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Vinorelbine.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Vinorelbine.
Ribociclib Ribociclib The metabolism of Vinorelbine can be decreased when combined with Ribociclib.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Vinorelbine can be increased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Vinorelbine.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Vinorelbine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Vinorelbine.
Deflazacort Deflazacort The metabolism of Deflazacort can be increased when combined with Vinorelbine.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Vinorelbine.
Sarilumab Injection Sarilumab Injection The metabolism of Sarilumab can be increased when combined with Vinorelbine.
Midostaurin Midostaurin The metabolism of Vinorelbine can be increased when combined with Midostaurin.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Enasidenib can be increased when combined with Vinorelbine.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Vinorelbine can be increased when combined with Fosaprepitant.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Vinorelbine.
Acalabrutinib Acalabrutinib The metabolism of Vinorelbine can be decreased when combined with Acalabrutinib.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vinorelbine.
Letermovir Letermovir The metabolism of Letermovir can be decreased when combined with Vinorelbine.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Vinorelbine.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Vinorelbine.
Apalutamide Apalutamide The metabolism of Vinorelbine can be increased when combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Penicillamine.
Fostamatinib Fostamatinib The metabolism of Vinorelbine can be decreased when combined with Fostamatinib.
Baricitinib Baricitinib The risk or severity of adverse effects can be increased when Vinorelbine is combined with Baricitinib.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Vinorelbine.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Vinorelbine.
Encorafenib Encorafenib The metabolism of Encorafenib can be decreased when combined with Vinorelbine.
Ivosidenib Ivosidenib The metabolism of Vinorelbine can be increased when combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Vinorelbine.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Vinorelbine.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Vinorelbine.
Duvelisib Duvelisib The metabolism of Vinorelbine can be decreased when combined with Duvelisib.
Stiripentol Stiripentol The metabolism of Vinorelbine can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The metabolism of Vinorelbine can be decreased when combined with Gilteritinib.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of peripheral neuropathy can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vinorelbine.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection Paclitaxel may increase the neurotoxic activities of Vinorelbine.
Rifamycin Rifamycin The metabolism of Vinorelbine can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Vinorelbine can be decreased when combined with Prucalopride.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Emapalumab can be increased when combined with Vinorelbine.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Vinorelbine is combined with Siponimod.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Vinorelbine.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Risankizumab.
Alpelisib Alpelisib The metabolism of Vinorelbine can be increased when combined with Alpelisib.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Vinorelbine.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Vinorelbine.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Vinorelbine.
Pitolisant Pitolisant The serum concentration of Vinorelbine can be decreased when it is combined with Pitolisant.
Lefamulin Lefamulin The serum concentration of Vinorelbine can be increased when it is combined with Lefamulin.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be increased when combined with Vinorelbine.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Vinorelbine can be increased when combined with Fosphenytoin.
Voxelotor Voxelotor The serum concentration of Vinorelbine can be increased when it is combined with Voxelotor.
Tazemetostat Tazemetostat The metabolism of Vinorelbine can be decreased when combined with Tazemetostat.
Cenobamate Cenobamate The serum concentration of Vinorelbine can be decreased when it is combined with Cenobamate.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ozanimod.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Vinorelbine.
Octreotide Octreotide The serum concentration of Vinorelbine can be increased when it is combined with Octreotide.
Pralsetinib Pralsetinib The metabolism of Vinorelbine can be increased when combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Vinorelbine can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection Vinorelbine may increase the neurotoxic activities of Naxitamab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Vinorelbine can be decreased when combined with Drospirenone.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Vinorelbine can be increased when combined with Vitamin E.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Vinorelbine.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Vinorelbine.
Trazodone Trazodone The metabolism of Trazodone can be decreased when combined with Vinorelbine.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Vinorelbine is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Vinorelbine.
Phenobarbital Phenobarbital The metabolism of Vinorelbine can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Methotrexate.
Primidone Primidone The metabolism of Vinorelbine can be increased when combined with Primidone.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be increased when combined with Vinorelbine.
Diazepam Diazepam The metabolism of Vinorelbine can be decreased when combined with Diazepam.
Lorazepam Lorazepam The metabolism of Vinorelbine can be decreased when combined with Lorazepam.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Vinorelbine.
Codeine Codeine The metabolism of Codeine can be decreased when combined with Vinorelbine.
Bromocriptine Bromocriptine The metabolism of Vinorelbine can be decreased when combined with Bromocriptine.
Tranylcypromine Tranylcypromine The metabolism of Vinorelbine can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Vinorelbine can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Procarbazine.
Tetracycline Tetracycline The metabolism of Vinorelbine can be decreased when combined with Tetracycline.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Vinorelbine.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Vinorelbine.
Thioridazine Thioridazine The metabolism of Thioridazine can be decreased when combined with Vinorelbine.
Trifluoperazine Trifluoperazine Vinorelbine may increase the neurotoxic activities of Trifluoperazine.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Vinorelbine.
Oxycodone Oxycodone The metabolism of Oxycodone can be decreased when combined with Vinorelbine.
Methadone Methadone The metabolism of Methadone can be increased when combined with Vinorelbine.
Oxybutynin Oxybutynin The metabolism of Vinorelbine can be decreased when combined with Oxybutynin.
Benztropine Benztropine The metabolism of Benzatropine can be decreased when combined with Vinorelbine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Vinorelbine.
Orphenadrine Orphenadrine The metabolism of Vinorelbine can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Vinorelbine.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Azathioprine.
Fluphenazine Fluphenazine Vinorelbine may increase the neurotoxic activities of Fluphenazine.
Phentermine Phentermine The metabolism of Vinorelbine can be decreased when combined with Phentermine.
Amoxapine Amoxapine The metabolism of Amoxapine can be decreased when combined with Vinorelbine.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The metabolism of Vinorelbine can be increased when combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Lomustine.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Vinorelbine.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dactinomycin.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be increased when combined with Vinorelbine.
Molindone Molindone Vinorelbine may increase the neurotoxic activities of Molindone.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Vinorelbine.
Hydralazine Hydralazine The metabolism of Vinorelbine can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The metabolism of Vinorelbine can be decreased when combined with Cimetidine.
Warfarin Warfarin The metabolism of Vinorelbine can be increased when combined with Warfarin.
Loperamide Loperamide The metabolism of Loperamide can be decreased when combined with Vinorelbine.
Promethazine Promethazine The metabolism of Promethazine can be decreased when combined with Vinorelbine.
Daunorubicin Daunorubicin The metabolism of Daunorubicin can be decreased when combined with Vinorelbine.
Griseofulvin Griseofulvin The metabolism of Vinorelbine can be increased when combined with Griseofulvin.
Digoxin Digoxin Digoxin may decrease the cardiotoxic activities of Vinorelbine.
Loxapine Loxapine Vinorelbine may increase the neurotoxic activities of Loxapine.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Vinorelbine.
Quinine Quinine The metabolism of Quinine can be increased when combined with Vinorelbine.
Calcitriol Calcitriol The metabolism of Vinorelbine can be increased when combined with Calcitriol.
Sulfinpyrazone Sulfinpyrazone The metabolism of Vinorelbine can be increased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Vinorelbine.
Clindamycin Injection Clindamycin Injection The serum concentration of Clindamycin can be increased when it is combined with Vinorelbine.
Secobarbital Secobarbital The metabolism of Vinorelbine can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Vinorelbine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Vinorelbine.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Vinorelbine.
Probenecid Probenecid The metabolism of Vinorelbine can be increased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Vinorelbine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Vinorelbine.
Isoniazid Isoniazid The metabolism of Vinorelbine can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Vinorelbine can be increased when combined with Rifampicin.
Valproic Acid Valproic Acid The metabolism of Vinorelbine can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be increased when combined with Vinorelbine.
Mitomycin Mitomycin The risk or severity of bronchospasm, shortness of breath, and dyspnea can be increased when Vinorelbine is combined with Mitomycin.
Methimazole Methimazole The metabolism of Methimazole can be decreased when combined with Vinorelbine.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Vinorelbine is combined with Propylthiouracil.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Vinorelbine.
Cyclobenzaprine Cyclobenzaprine Vinorelbine may increase the neurotoxic activities of Cyclobenzaprine.
Niacin Niacin The metabolism of Vinorelbine can be decreased when combined with Niacin.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Vinorelbine.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Vinorelbine.
Methyclothiazide Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Vinorelbine.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Vinorelbine.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Vinorelbine.
Danazol Danazol The metabolism of Vinorelbine can be decreased when combined with Danazol.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Vinorelbine.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Vinorelbine.
Amphotericin B Injection Amphotericin B Injection The metabolism of Vinorelbine can be decreased when combined with Amphotericin B.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mercaptopurine.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Vinorelbine.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Vinorelbine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Fluorouracil.
Colchicine Colchicine The metabolism of Colchicine can be increased when combined with Vinorelbine.
Cephalexin Cephalexin The metabolism of Vinorelbine can be decreased when combined with Cephalexin.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dacarbazine.
Acetazolamide Acetazolamide The metabolism of Vinorelbine can be decreased when combined with Acetazolamide.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Vinorelbine.
Ketoconazole Ketoconazole The metabolism of Vinorelbine can be decreased when combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Thiotepa.
Vincristine Injection Vincristine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Vincristine.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Vinorelbine.
Vinblastine Vinblastine The metabolism of Vinblastine can be increased when combined with Vinorelbine.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Vinorelbine.
Thiothixene Thiothixene Vinorelbine may increase the neurotoxic activities of Thiothixene.
Aspirin Aspirin The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Vinorelbine.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Vinorelbine.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Vinorelbine.
Nifedipine Nifedipine The metabolism of Nifedipine can be increased when combined with Vinorelbine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Vinorelbine.
Verapamil Verapamil The metabolism of Vinorelbine can be decreased when combined with Verapamil.
Atenolol Atenolol The metabolism of Atenolol can be decreased when combined with Vinorelbine.
Pindolol Pindolol The metabolism of Pindolol can be decreased when combined with Vinorelbine.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Vinorelbine.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be increased when combined with Vinorelbine.
Glyburide Glyburide The metabolism of Vinorelbine can be decreased when combined with Glyburide.
Dicloxacillin Dicloxacillin The metabolism of Vinorelbine can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Vinorelbine can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The risk or severity of bleeding can be increased when Pentoxifylline is combined with Vinorelbine.
Pentamidine Injection Pentamidine Injection The metabolism of Pentamidine can be decreased when combined with Vinorelbine.
Labetalol Labetalol The metabolism of Labetalol can be decreased when combined with Vinorelbine.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Vinorelbine.
Amiodarone Amiodarone The metabolism of Vinorelbine can be decreased when combined with Amiodarone.
Buspirone Buspirone The metabolism of Buspirone can be decreased when combined with Vinorelbine.
Lovastatin Lovastatin The metabolism of Vinorelbine can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The metabolism of Vinorelbine can be decreased when combined with Ciprofloxacin.
Fluoxetine Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Vinorelbine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Vinorelbine.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Vinorelbine is combined with Clozapine.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Vinorelbine is combined with Idarubicin.
Didanosine Didanosine Vinorelbine may increase the neurotoxic activities of Didanosine.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pentostatin.
Clarithromycin Clarithromycin The metabolism of Vinorelbine can be decreased when combined with Clarithromycin.
Felodipine Felodipine The metabolism of Vinorelbine can be decreased when combined with Felodipine.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Vinorelbine.
Filgrastim Injection Filgrastim Injection The risk or severity of peripheral neuropathy can be increased when Filgrastim is combined with Vinorelbine.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinorelbine.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Vinorelbine.
Itraconazole Itraconazole The metabolism of Vinorelbine can be decreased when combined with Itraconazole.
Sargramostim Sargramostim The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinorelbine.
Rifabutin Rifabutin The metabolism of Vinorelbine can be increased when combined with Rifabutin.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Vinorelbine.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Vinorelbine.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Vinorelbine.
Isradipine Isradipine The metabolism of Vinorelbine can be decreased when combined with Isradipine.
Omeprazole Omeprazole The metabolism of Vinorelbine can be increased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Vinorelbine can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Vinorelbine.
Venlafaxine Venlafaxine The metabolism of Venlafaxine can be decreased when combined with Vinorelbine.
Stavudine Stavudine Vinorelbine may increase the neurotoxic activities of Stavudine.
Famciclovir Famciclovir The metabolism of Vinorelbine can be decreased when combined with Famciclovir.
Fluvoxamine Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Vinorelbine.
Nefazodone Nefazodone The metabolism of Nefazodone can be decreased when combined with Vinorelbine.
Losartan Losartan The metabolism of Vinorelbine can be decreased when combined with Losartan.
Tramadol Tramadol The metabolism of Vinorelbine can be decreased when combined with Tramadol.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Carboplatin.
Lansoprazole Lansoprazole The metabolism of Vinorelbine can be increased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Vinorelbine.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Vinorelbine.
Nicardipine Nicardipine The metabolism of Vinorelbine can be decreased when combined with Nicardipine.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Vinorelbine.
Saquinavir Saquinavir The metabolism of Vinorelbine can be decreased when combined with Saquinavir.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Vinorelbine.
Anastrozole Anastrozole The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Anastrozole.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Gemcitabine.
Ritonavir Ritonavir The serum concentration of Ritonavir can be increased when it is combined with Vinorelbine.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Vinorelbine.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Vinorelbine.
Zafirlukast Zafirlukast The metabolism of Vinorelbine can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Vinorelbine.
Topiramate Topiramate The metabolism of Vinorelbine can be increased when combined with Topiramate.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Vinorelbine.
Azithromycin Azithromycin The metabolism of Vinorelbine can be decreased when combined with Azithromycin.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Vinorelbine.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Vinorelbine.
Bicalutamide Bicalutamide The metabolism of Vinorelbine can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Vinorelbine.
Propafenone Propafenone The metabolism of Propafenone can be decreased when combined with Vinorelbine.
Raloxifene Raloxifene The metabolism of Vinorelbine can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Vinorelbine can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Vinorelbine.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Vinorelbine.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Vinorelbine.
Citalopram Citalopram The metabolism of Citalopram can be decreased when combined with Vinorelbine.
Capecitabine Capecitabine The risk or severity of adverse effects can be increased when Vinorelbine is combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Vinorelbine can be increased when combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Vinorelbine.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Vinorelbine.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Vinorelbine.
Tolterodine Tolterodine The metabolism of Tolterodine can be decreased when combined with Vinorelbine.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Vinorelbine is combined with Thalidomide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Vinorelbine.
Galantamine Galantamine The metabolism of Galantamine can be decreased when combined with Vinorelbine.
Rabeprazole Rabeprazole The metabolism of Vinorelbine can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Vinorelbine can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists